Table 1.
Essential information and quality assessment of included literature in systematic review of positive NTM from patients with HIV/AIDS in China
| Observed indicators |
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Study
|
Study design
|
Location (W/E/N/S/C)
|
Survey date
|
Total sample size
|
Men, n (%)
|
Clinical symptoms
|
Laboratory tests
|
Thoracic imaging manifestations
|
Species distribution
|
Treatment outcome
|
||||
| Song et al., 2011 [39] |
Case-series study |
Beijing (N) |
2009-2010 |
5 |
4 (80) |
No |
Yes |
Yes |
Yes |
No |
||||
| Ding et al., 2022 [40] |
Cross-sectional study |
Beijing (N) |
2016-2021 |
71 |
62 (87.3) |
Yes |
Yes |
Yes |
Yes |
Yes |
||||
| Wang et al., 2017 [41] |
Cross-sectional study |
Beijing (N) |
2009-2015 |
33 |
28 (84.8) |
No |
Yes |
Yes |
No |
Yes |
||||
| Wu et al., 2017 [42] |
Cross-sectional study |
Guangdong (S) |
2008-2015 |
31 |
28 (90.3) |
Yes |
Yes |
Yes |
Yes |
No |
||||
| Cao et al., 2021 [43] |
Cross-sectional study |
Guangdong (S) |
2014-2019 |
43 |
38 (88.4) |
Yes |
Yes |
No |
Yes |
No |
||||
| Jiang et al., 2014 [44] |
Cross-sectional study |
Guangdong (S) |
2006-2010 |
13 |
13 (100) |
Yes |
No |
Yes |
No |
No |
||||
| Meng et al., 2008 [45] |
Cross-sectional study |
Guangxi (S) |
2006-2007 |
36 |
NA |
Yes |
Yes |
Yes |
No |
Yes |
||||
| Meng et al., 2018 [46] |
Cross-sectional study |
Guangxi (S) |
2012-2015 |
29 |
19 (65.5) |
Yes |
Yes |
Yes |
No |
Yes |
||||
| R. Lan et al., 2011 [47] |
Case-control study |
Guangxi (S) |
2005-2008 |
102 |
82 (80.4) |
No |
Yes |
No |
Yes |
No |
||||
| Zhang et al., 2011 [48] |
Case-control study |
Guangxi (S) |
2006-2008 |
82 |
NA |
Yes |
No |
No |
No |
No |
||||
| Yin et al., 2015 [49] |
Cross-sectional study |
Guangxi (S) |
2009-2012 |
97 |
77 (79.4) |
Yes |
No |
Yes |
No |
Yes |
||||
| Huang et al., 2022 [50] |
Cross-sectional study |
Guangxi (S) |
2018-2019 |
11 |
NA |
No |
Yes |
No |
Yes |
No |
||||
| Zhou et al., 2013 [51] |
Cross-sectional study |
Guangxi (S) |
2006-2010 |
135 |
106 (78.5) |
No |
No |
No |
Yes |
No |
||||
| Wang et al., 2022 [52] |
Cross-sectional study |
Hubei (C) |
2019-2021 |
9 |
8 (88.9) |
Yes |
Yes |
No |
No |
Yes |
||||
| Li et al., 2016 [53] |
Cross-sectional study |
Hubei (C) |
2012-2015 |
27 |
24 (88.9) |
Yes |
Yes |
Yes |
No |
No |
||||
| Deng et al., 2013 [54] |
Cross-sectional study |
Hunan (C) |
2008-2011 |
63 |
NA |
Yes |
Yes |
Yes |
No |
No |
||||
| Wang et al., 2021 [55] |
Cross-sectional study |
Jiangsu (E) |
2017-2020 |
97 |
NA |
No |
Yes |
No |
Yes |
No |
||||
| Huang et al., 2021 [56] |
Cross-sectional study |
Jiangxi (E) |
2017-2020 |
22 |
16 (72.7) |
No |
Yes |
Yes |
Yes |
No |
||||
| Li, 2018 [57] |
Cross-sectional study |
Shaanxi (W) |
2016-2017 |
50 |
50 (100) |
Yes |
Yes |
Yes |
No |
No |
||||
| Zhu et al., 2013 [58] |
Cross-sectional study |
Shanghai (E) |
2007-2012 |
27 |
27 (100) |
Yes |
Yes |
Yes |
No |
No |
||||
| Sun et al., 2019 [59] |
Cross-sectional study |
Shanghai (E) |
2006-2015 |
377 |
329 (87.3) |
No |
No |
No |
Yes |
No |
||||
| Tian at al., 2022 [60] |
Case-control study |
Shanghai (E) |
2015-2021 |
169 |
161 (95.3) |
No |
Yes |
No |
No |
No |
||||
| Wang et al., 2019 [61] |
Cross-sectional study |
Sichuan (W) |
2014-2018 |
59 |
50 (84.7) |
Yes |
Yes |
Yes |
Yes |
No |
||||
| Zhang et al., 2021 [62] |
Cross-sectional study |
Yunnan (W) |
2012-2019 |
90 |
69 (76.7) |
No |
Yes |
No |
Yes |
No |
||||
| Li et al., 2018 [63] |
Cross-sectional study |
Chongqing (W) |
2013-2015 |
23 |
16 (69.6) |
Yes |
Yes |
Yes |
No |
No |
||||
| Liu et al., 2021 [64] |
Cross-sectional study |
Chongqing (W) |
2019-2020 |
44 |
34 (77.3) |
Yes |
Yes |
No |
Yes |
No |
||||
| Chou et al., 2011 [65] |
Cross-sectional study |
Taiwan (E) |
2004-2008 |
22 |
21 (95.5) |
Yes |
No |
No |
Yes |
No |
||||
| Chiang et al., 2020 [66] | Retrospective cohort study | Taiwan (E) | 1996-2016 | 94 | 86 (91.5) | Yes | No |
Yes |
No |
No | ||||
NA – not available, W – western region, E – eastern region, N – northern region, S – southern region, C – central region